MedPath

Evaluation of Renal Damage After PCNL and ESWL Using Novel RNA Based Biomarkers

Not Applicable
Conditions
Percutaneous Nephrolithotomy
Acute Kidney Injury
Renal Calculi
Extracorporeal Shockwave Lithotripsy
Interventions
Procedure: Extracorporeal Shock Wave Lithotripsy
Procedure: Percutaneous nephrolithotomy
Registration Number
NCT05077007
Lead Sponsor
Ain Shams University
Brief Summary

The study evaluate the damage effect of ESWL and PCNL on kidney tissue by measuring non-coding lnc-RNA profile in urine before and after ESWL and PCNL procedures

Detailed Description

The study evaluate the damage effect of ESWL and PCNL on kidney tissue by measuring non-coding lnc-RNA profile in urine before and after ESWL and PCNL procedures and assess their usefulness as diagnostic biomarkers for AKI and the relationship between the selected RNA based biomarker panel and clinicopathological changes of patients.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
75
Inclusion Criteria
  • Inclusion criteria for patients :

    1. Patients undergoing treatment for a stone(s) located in the kidney less than 2 cm
    2. Radiopaque stone
    3. Able and willing to give informed consent

Inclusion criteria for Healthy volunteers

  1. No history of kidney or stone disease
  2. Asymptomatic
  3. No indwelling ureteral stent
  4. Willing to provide medical history information
  5. Able and willing to give informed consent
Read More
Exclusion Criteria
  • Exclusion criteria for patients

    1. Active urinary tract infection
    2. Bleeding disorder
    3. Chronic renal failure (eGFR<30)
    4. Ureteral stone
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Extracorporeal Shock Wave LithotripsyExtracorporeal Shock Wave Lithotripsypatients suffering of pelvic renal stones underwent Extracorporeal Shock Wave Lithotripsy
Percutaneous nephrolithotomyPercutaneous nephrolithotomypatients suffering of pelvic renal stones underwent Percutaneous nephrolithotomy
Primary Outcome Measures
NameTimeMethod
Evaluation of renal damage after PCNL and ESWL using novel RNA based BiomarkersBefore the procedure by 2hours and after the procedure by 2 and 24 hours

Evaluation of kidney injury after procedures PCNL and ESWL by measuring the change of the level of novel non-coding lnc-RNA profile in urine

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Urology Department, Faculty of Medicine, Ain Shams University

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath